AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Patients have used proton pump inhibitors to stop gastric acid production for up to 17 years without increasing their risk of developing gastric carcinoids.
This finding is "reassuring for patients regularly using a proton pump inhibitor to treat gastroesophageal reflux or Barrett's esophagus," Dr. Fathia Gibril said in a poster presentation at the annual Digestive Disease Week.
When omeprazole (Prilosec) came onto the market in the mid-1980s as the first proton pump inhibitor approved for use in the United States, many experts were concerned that long-term, chronic use might raise a patient's risk of gastric carcinoids. This cancer appeared at an accelerated rate in some of the animal models that had been used to test the safety of long, uninterrupted use.
Dr. Gibril and her associates reviewed the experience of 143 patients who have undergone continuous treatment with omeprazole for ...
Source: HighBeam Research, Proton pump inhibitor safety. (GI Disorders).